
Clocks across the majority of European countries are set to go forward by one hour early on Sunday as the continent moves to daylight saving time, also known as summer time.
Clocks in most European nations including Germany advance by one hour at 2 am (0100 GMT) to 3 am, heralding longer evenings and brighter days.
This means that for the coming months parts of Europe will be on Central European Summer Time (CEST), before moving back to Central European Time (CET) in the autumn, when clocks go back again by an hour on October 25.
The aim of the change is to make better use of daylight in the shorter days of the winter in the northern hemisphere.
The signal for the automatic changeover of the clocks in Germany comes from the Federal Institute of Physics and Metrology (PTB) in the northern city of Braunschweig, also known as Brunswick in English.
The institute's experts ensure that radio-controlled clocks, station clocks and many industrial clocks are supplied with the signal via a long-wave transmitter called DCF77 in Mainflingen near Frankfurt.
LATEST POSTS
- 1
Pick Your #1 breakfast food - 2
Northern lights chances rise for Christmas as space weather remains unsettled - 3
4 Electric Vehicle Brands: Execution, Unwavering quality, and Development - 4
Go With The Breeze: Grand Paragliding Spots On the planet - 5
EU-funded BioSupPack project turns brewery waste into bioplastics
Ski Resorts Universally: A Colder time of year Wonderland Guide
Share your pick for the miniature headphones that you generally suggest!
Industrial zone damaged in Negev, falls in Sharon area after Iran fires missiles towards Israel
Was This Driver Simply Having Some good times Or Behaving Like An Ass?
Artemis II astronauts will see parts of the moon no human has before. Here’s how
Experiences in Natural life Protection: Individual Progressives' Excursions
NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby
Yemen’s Aden airport shut by STC-backed transport minister, Saudi source says
Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer













